Quasar Medical Expands Global CDMO Operations with Strategic Acquisition

Quasar Medical Expands Global CDMO Operations

Quasar Medical, a leader in the manufacturing of interventional and minimally invasive medical devices, recently made waves in the industry by enhancing its global Contract Development and Manufacturing Organization (CDMO) platform. This strategic move significantly broadens Quasar's end-to-end capabilities, ultimately increasing value for medical device OEMs and innovators.

Acquisition Details

Quasar Medical announced the successful completion of its acquisition of Nordson Corporation's design & development contract manufacturing businesses. This acquisition includes facilities located in key MedTech regions and greatly expands Quasar's operations.

Strategic Importance

The addition of these facilities marks a transformative step for Quasar, allowing the company to seamlessly offer customers a concept-to-commercialization journey. With nearly 200 new staff members joining the team, including skilled development engineers and technicians, the company aims to foster an environment of growth and innovation.

As Quasar Medical moves forward, the commitment to serving customers effectively remains at the forefront. CEO Alex Wallstein stated, "This strategic acquisition marks an exciting new chapter for Quasar and the customers we serve. By combining our manufacturing excellence with world-class design, development, and assembly expertise, we can expand our global reach and enhance our customer partnerships."

Facility Enhancements

The acquisition bolsters Quasar's global presence with two FDA-registered, ISO 13485-certified facilities. These facilities are positioned in vital markets, enabling improved access and proximity for customers. The Galway facility is set to become a hub for innovation in developing advanced medical device components, such as extrusions, braiding, and complex catheters, enhancing Quasar's design, prototyping, and clinical innovation capabilities.

Production Advancements

On the other hand, the Tecate facility will focus on high-volume manufacturing, establishing cost-effective solutions for transitioning from product development to commercialization. COO Aviel Bohnik remarked, "This is a pivotal milestone for Quasar, positioning us as a vital partner to our customers. With the addition of these facilities, we offer a differentiated platform that delivers innovation and speed to market, enhancing our overall operational excellence across regions."

Improving Customer Solutions

The integration of Nordson Medical's capabilities into Quasar’s global platform allows for a more seamless approach to developing complex interventional devices. This includes:

• Advanced product development and rapid prototyping in Galway
• Expertise in design-for-manufacturing, balloon catheter, and shaft development
• Manufacturing excellence in Tecate, including molding and packaging processes

This acquisition significantly enhances Quasar's cleanroom footprint, deepening expertise in crucial areas like extrusions and delivery systems, and providing ample room for growth at both new sites. The benefits for customers include improved access in global markets, faster development timelines, enhanced quality controls, and cost-effective production methods.

Commitment to Collaboration

Quasar is dedicated to working closely with Nordson during the transition, ensuring stability for employees, customers, and suppliers alike. The emphasis on collaboration aims to strengthen relationships, ensuring that the integration process runs smoothly and efficiently.

About Quasar Medical

Quasar Medical is a prominent Contract Development and Manufacturing Organization (CDMO) specializing in delivering comprehensive solutions for interventional and minimally invasive medical devices. With 11 facilities worldwide and a workforce exceeding 4,300 employees, Quasar is recognized for its capabilities in producing catheter systems, balloon technologies, micro-EM sensors, and complex assemblies. Headquartered in Singapore, the company prides itself on providing fully integrated device solutions, encompassing design, prototyping, and scalable manufacturing that adheres to the highest quality standards. Quasar Medical serves leading medical device OEMs and innovators, ensuring exceptional scalability and speed to market.

Frequently Asked Questions

What does Quasar Medical specialize in?

Quasar Medical specializes in the design, development, and manufacturing of interventional and minimally invasive medical devices.

What recent acquisition has Quasar Medical completed?

Quasar Medical recently acquired Nordson Corporation's manufacturing facilities in Galway and Tecate.

How does this acquisition benefit Quasar's operations?

The acquisition expands Quasar's capabilities, enhances product development, and improves manufacturing processes significantly.

What kind of facilities has Quasar acquired?

Quasar now operates two FDA-registered, ISO 13485-certified facilities that enhance its global presence in key MedTech regions.

What is Quasar's commitment following the acquisition?

Quasar is committed to ensuring a seamless transition for all stakeholders, including employees and customers, while fostering innovation and operational excellence.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.